Inclusion Criteria : 
  -  Women over age  18 with a core biopsy proven borderline or high - risk breast lesion that requires further excision for management based on the surgeon's assessment
  -  Informed consent must be obtained . 
Exclusion Criteria : 
  -  Women who are considered high - risk based on a greater than  25 % lifetime risk of breast cancer as per the IBIS ( International Breast Cancer Intervention Study ) Breast Cancer Risk Evaluation Tool
  -  Pathology that is felt to be discordant with imaging
  -  Extensive calcifications extending more than  20 mm and / or masses greater than  30 mm
  -  The following lesions will be excluded based on their increased risk of upstaging; lesions ( other than fibroadenomas , phyllodes and papillomas ) that are associated with a palpable mass , ADH ( atypical ductal hyperplasia ) with high - risk features ( ADH with zonal necrosis , significant cytological atypia or more than  2 foci )  , LCIS ( lobular carcinoma in situ ) with high - risk features ( associated with ADH , pleomorphic LCIS , zonal necrosis and >  4 foci ) or discordant with imaging , papilloma with atypia , and spindle cell lesion ( especially if there is atypia )  . 
  -  Lesions that are suspicious for borderline or malignant Phyllodes , DCIS ( ductal carcinoma in situ )  , invasive mammary carcinoma , or encapsulated papillary carcinoma
  -  Any lesion that either the radiologist , pathologist or surgeon feels is not amenable to VAPE or surgical excision